History of Health Economics (HE), Pharmacoeconomics (PE) and Health Technology Assessment (HTA); Importance, Principles and Practices of HE, PE and HTA, EU ‘Cross-border Healthcare’ Directive, EUnetHTA Core Model, HEOR Overview
Health Policy Analysis
Clinical Research Program (RCTs) vs. RWE Data (Registries, Pharmacovigilance); Systematic Reviews in HE, PE and HTA
Economic Evaluation – Analyses in Healthcare
Institutional Management and Budget Impact Assessment Implementation of HE Outcomes into Clinical Practice, Dissemination and Transfer of knowledge in PE/HTA and HE
Transferability of Data, Outcomes and Results, local adaptation of HEOR; Ethics, Social, Cultural, and other soft domains in HE, PE and HTA
Managed Entry agreements, Coverage with Evidence Development, Payments by Results, Compassionate Use Programs, Compulsory Licensing, Google/Netflix Model in Healthcare